Magallanes, Virgin F.
HRN: 28-01-19 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/04/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/04/2025
11/11/2025
IV
500 MG
Q8HRS
CALCULOUS CHOLECYSTITIS
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes